In 2013, she was treated with eltrombopag (a thrombopoietin receptor agonist (TPO-RA)) at a dose alternating between 25 and 37.5 mg daily, after declining romiplostim (a TPO-RA). Here, TPO is linked to rheumatoid arthritis.